Search

Ilia I. Ouspenski

Examiner (ID: 1237)

Most Active Art Unit
1644
Art Unit(s)
1644
Total Applications
1566
Issued Applications
1023
Pending Applications
156
Abandoned Applications
432

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 12112979 [patent_doc_number] => 09868961 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-16 [patent_title] => 'Methods and compositions for localized secretion of anti-CTLA-4 antibodies' [patent_app_type] => utility [patent_app_number] => 12/294889 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10917 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12294889 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/294889
Methods and compositions for localized secretion of anti-CTLA-4 antibodies Mar 29, 2007 Issued
Array ( [id] => 5246960 [patent_doc_number] => 20070243194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Anti-IGF-1R antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/727887 [patent_app_country] => US [patent_app_date] => 2007-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 89795 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20070243194.pdf [firstpage_image] =>[orig_patent_app_number] => 11727887 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/727887
Anti-IGF-1R antibodies and uses thereof Mar 27, 2007 Issued
Array ( [id] => 6220625 [patent_doc_number] => 20100055720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'USE OF THE 4-lBB RECEPTOR FOR IDENTIFYING AND/OR SEPARATING ACTIVATED REGULATORY TH CELLS (TREG)' [patent_app_type] => utility [patent_app_number] => 12/294181 [patent_app_country] => US [patent_app_date] => 2007-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9159 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055720.pdf [firstpage_image] =>[orig_patent_app_number] => 12294181 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/294181
Use of the 4-1BB receptor for identifying and/or separating activated regulatory Th cells (Treg) Mar 25, 2007 Issued
Array ( [id] => 5415882 [patent_doc_number] => 20090041769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Methods of treatment using CTLA4 mutant molecules' [patent_app_type] => utility [patent_app_number] => 11/725762 [patent_app_country] => US [patent_app_date] => 2007-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13676 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20090041769.pdf [firstpage_image] =>[orig_patent_app_number] => 11725762 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/725762
Methods of treatment using CTLA4 mutant molecules Mar 19, 2007 Issued
Array ( [id] => 4687695 [patent_doc_number] => 20080031876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'CTLA4 molecules and IL4-binding molecules and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/725384 [patent_app_country] => US [patent_app_date] => 2007-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 22467 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20080031876.pdf [firstpage_image] =>[orig_patent_app_number] => 11725384 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/725384
Soluble CTLA4 mutant molecules Mar 18, 2007 Issued
Array ( [id] => 5258732 [patent_doc_number] => 20070212364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'METHODS FOR DECREASING THE TOXIC EFFECTS OF NICOTINE ON FETUSES IN PREGNANT WOMEN' [patent_app_type] => utility [patent_app_number] => 11/679022 [patent_app_country] => US [patent_app_date] => 2007-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4627 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20070212364.pdf [firstpage_image] =>[orig_patent_app_number] => 11679022 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/679022
Methods for decreasing the toxic effects of nicotine on fetuses in pregnant women Feb 25, 2007 Issued
Array ( [id] => 4771408 [patent_doc_number] => 20080057066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'METHODS AND COMPOSITIONS FOR TARGETING RELT' [patent_app_type] => utility [patent_app_number] => 11/674074 [patent_app_country] => US [patent_app_date] => 2007-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 40659 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057066.pdf [firstpage_image] =>[orig_patent_app_number] => 11674074 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/674074
METHODS AND COMPOSITIONS FOR TARGETING RELT Feb 11, 2007 Abandoned
Array ( [id] => 4988129 [patent_doc_number] => 20070154468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Use of CD28-specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections' [patent_app_type] => utility [patent_app_number] => 11/702560 [patent_app_country] => US [patent_app_date] => 2007-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7531 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20070154468.pdf [firstpage_image] =>[orig_patent_app_number] => 11702560 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/702560
Use of CD28-specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections Feb 5, 2007 Abandoned
Array ( [id] => 1077095 [patent_doc_number] => 07615611 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-10 [patent_title] => 'Human cytokine receptor' [patent_app_type] => utility [patent_app_number] => 11/670074 [patent_app_country] => US [patent_app_date] => 2007-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61353 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/615/07615611.pdf [firstpage_image] =>[orig_patent_app_number] => 11670074 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/670074
Human cytokine receptor Jan 31, 2007 Issued
Array ( [id] => 303439 [patent_doc_number] => 07534575 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-19 [patent_title] => 'Method for detecting cancer using an antibody to Zcytor16' [patent_app_type] => utility [patent_app_number] => 11/670209 [patent_app_country] => US [patent_app_date] => 2007-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61357 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/534/07534575.pdf [firstpage_image] =>[orig_patent_app_number] => 11670209 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/670209
Method for detecting cancer using an antibody to Zcytor16 Jan 31, 2007 Issued
Array ( [id] => 191033 [patent_doc_number] => 07642345 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-05 [patent_title] => 'Polynucleotides encoding human cytokine receptor' [patent_app_type] => utility [patent_app_number] => 11/670147 [patent_app_country] => US [patent_app_date] => 2007-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61361 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/642/07642345.pdf [firstpage_image] =>[orig_patent_app_number] => 11670147 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/670147
Polynucleotides encoding human cytokine receptor Jan 31, 2007 Issued
Array ( [id] => 4927450 [patent_doc_number] => 20080166813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'Human OX2 receptors' [patent_app_type] => utility [patent_app_number] => 11/700630 [patent_app_country] => US [patent_app_date] => 2007-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14405 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20080166813.pdf [firstpage_image] =>[orig_patent_app_number] => 11700630 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/700630
Human OX2 receptors Jan 29, 2007 Issued
Array ( [id] => 5219293 [patent_doc_number] => 20070160604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'METHODS OF IDENTIFYING COMPOUNDS CAPABLE OF MODULATING T CELL IMMUNE RESPONSES INVOLVING SEMA4A PROTEIN' [patent_app_type] => utility [patent_app_number] => 11/668121 [patent_app_country] => US [patent_app_date] => 2007-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9829 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20070160604.pdf [firstpage_image] =>[orig_patent_app_number] => 11668121 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/668121
METHODS OF IDENTIFYING COMPOUNDS CAPABLE OF MODULATING T CELL IMMUNE RESPONSES INVOLVING SEMA4A PROTEIN Jan 28, 2007 Abandoned
Array ( [id] => 3530 [patent_doc_number] => 07815904 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-19 [patent_title] => 'Method of treating a pathological syndrome and a pharmaceutical agent' [patent_app_type] => utility [patent_app_number] => 11/656322 [patent_app_country] => US [patent_app_date] => 2007-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26179 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/815/07815904.pdf [firstpage_image] =>[orig_patent_app_number] => 11656322 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/656322
Method of treating a pathological syndrome and a pharmaceutical agent Jan 21, 2007 Issued
Array ( [id] => 4733381 [patent_doc_number] => 20080050360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'Method of treating a pathological syndrome and a pharmaceutical agent' [patent_app_type] => utility [patent_app_number] => 11/656218 [patent_app_country] => US [patent_app_date] => 2007-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26155 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20080050360.pdf [firstpage_image] =>[orig_patent_app_number] => 11656218 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/656218
Method of treating a pathological syndrome and a pharmaceutical agent Jan 21, 2007 Abandoned
Array ( [id] => 4733413 [patent_doc_number] => 20080050392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'Method of treating a pathological syndrome and a pharmaceutical agent' [patent_app_type] => utility [patent_app_number] => 11/656217 [patent_app_country] => US [patent_app_date] => 2007-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26153 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20080050392.pdf [firstpage_image] =>[orig_patent_app_number] => 11656217 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/656217
Method of treating hypertension disorder and a pharmaceutical agent Jan 21, 2007 Issued
Array ( [id] => 4733413 [patent_doc_number] => 20080050392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'Method of treating a pathological syndrome and a pharmaceutical agent' [patent_app_type] => utility [patent_app_number] => 11/656217 [patent_app_country] => US [patent_app_date] => 2007-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26153 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20080050392.pdf [firstpage_image] =>[orig_patent_app_number] => 11656217 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/656217
Method of treating hypertension disorder and a pharmaceutical agent Jan 21, 2007 Issued
Array ( [id] => 4657124 [patent_doc_number] => 20080025985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Method of treating a pathological syndrome and a pharmaceutical agent' [patent_app_type] => utility [patent_app_number] => 11/656225 [patent_app_country] => US [patent_app_date] => 2007-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26176 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20080025985.pdf [firstpage_image] =>[orig_patent_app_number] => 11656225 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/656225
Method of treating a pathological syndrome and a pharmaceutical agent Jan 21, 2007 Abandoned
Array ( [id] => 5159851 [patent_doc_number] => 20070172895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'CD86 and CD80 receptor competition assays' [patent_app_type] => utility [patent_app_number] => 11/656206 [patent_app_country] => US [patent_app_date] => 2007-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 8275 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20070172895.pdf [firstpage_image] =>[orig_patent_app_number] => 11656206 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/656206
CD86 and CD80 receptor competition assays Jan 21, 2007 Issued
Array ( [id] => 9026085 [patent_doc_number] => 08535664 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-17 [patent_title] => 'Method of treating a pathological syndrome and a pharmaceutical agent' [patent_app_type] => utility [patent_app_number] => 11/656226 [patent_app_country] => US [patent_app_date] => 2007-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26238 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11656226 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/656226
Method of treating a pathological syndrome and a pharmaceutical agent Jan 21, 2007 Issued
Menu